Back
Corporate News
GlaxoSmithKline Pharmaceuticals to review financial results at board meeting November 3, 2026
13-Oct-2026, 05:37
GlaxoSmithKline Pharmaceuticals Limited will hold a board meeting on Tuesday, November 3, 2026, to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2026, the company said in a filing to the BSE Limited and the National Stock Exchange of India Limited.
